Stillbirth Risk Identification Using Multiparametric Ultrasound
ConditionPerinatal Hypoxia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age19+
SponsorUniversity of British Columbia
About this trial
The goal of this observational study is to identify a novel biomarker for stillbirth.
Specifically the aim is to predict perinatal hypoxia using quantitative ultrasound from the placenta (QUS-P) between 35 and 37 weeks gestation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnant with singleton
Age 19 years or older
Provision of informed consent
Planning to deliver at BC Women's Hospital
Disqualifiers
Pregnant with multiples
Not planning to deliver at BC Women's Hospital
Less than 19 years of age
Greater than 38 weeks gestation
Trial population
Potential participants are recruited from the following sources: 1. South Community Birth Program 2. Maternal Fetal Medicine Clinics at BC Women's Hospital (EMMA and Fetal Monitoring)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Presence of Perinatal Hypoxia at 35-37 weeks gestation
Perinatal hypoxia is defined as meeting one or more of the following: 1. Apgar \< 7 at 5 minutes 2. Umbilical artery pH \< 7.1 3. Neonatal cardiac resuscitation performed (includes CPAP, intubation and ventilation, or cardiopulmonary resuscitation) 4. Neonatal encephalopathy (Severe brain injury diagnosed within the first 7 days of life defined as: was therapeutically cooled; and/or had decreased central tone or was comatose and had seizures of any kind; and/or had amplitude integrated electroencephalography (aEEG abnormality) in the first 24 hours of birth. )
Time frame
35-37 weeks gestationSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of British Columbia
Lead sponsor
Wellcome Trust
Collaborator
Source ClinicalTrials.gov